Sage Journals: Discover world-class research

Retricted access

Case report

First published 2013-9

Tyrosine kinase inhibitor induced pancreatitis

Adrienne Sevin, Adrienne Chen, Brad Atkinson

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2018-3

Drug–drug interactions in patients receiving tyrosine kinase inhibitors

Kristine L Keller, Miguel J Franquiz, Alison P Duffy [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2015

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

Nadine Kutsch, Reinhard Marks, Richard Ratei [...]

Biomarker Insights

Open access

Review article

First published 2020

Tyrosine Kinase Inhibitors in the Combination Therapy of HER2 Positive Breast Cancer

Xue Yang, Dapeng Wu, Shengli Yuan

Technology in Cancer Research & Treatment

Open access

Review article

First published 2024-09

Unveiling the Cardiotoxicity Conundrum: Navigating the Seas of Tyrosine Kinase Inhibitor Therapies

Jahanzaib Ekram, Azeem Rathore, Carlos Avila [...]

Cancer Control

Retricted access

Research article

First published 2024-12

Biomarker Testing and Role of Tyrosine Kinase Inhibitors and Immunotherapy for Esophageal Squamous Cell Carcinoma

Muftah Mahmud, Ananya Munjal, Malvi Savani [...]

Foregut: The Journal of the American Foregut Society

Retricted access

Case report

First published 2022-4

Tyrosine kinase inhibitor nilotinib induced palmoplantar erythrodysesthesia: A rare case

Muzeyyen Aslaner Ak, Pelin Ertop Doğan, Birsen Sahip

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2020-4

Outcomes of combination therapy with tyrosine kinase inhibitors and immune checkpoint inhibitors in metastatic renal cell carcinoma – A retrospective study

Nadya Jammal, Eva Pan, Michael Hurwitz [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2006-2

Lapatinib: A Novel Dual Tyrosine Kinase Inhibitor with Activity in Solid Tumors

Michael H Nelson, Christian R Dolder

Annals of Pharmacotherapy

Open access

Review article

First published 2011

Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib

Naveen S. Vasudev, James M.G. Larkin

Clinical Medicine Insights: Oncology

Search results